查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
北美微生物鑑定方法市場預測至 2030 年 - 區域分析 - 按方法和類型
市場調查報告書
商品編碼
1481977

北美微生物鑑定方法市場預測至 2030 年 - 區域分析 - 按方法和類型

North America Microbial Identification Methods Market Forecast to 2030 - Regional Analysis - By Method and Type
出版日期: | 出版商: The Insight Partners | 英文 96 Pages | 訂單完成後即時交付

價格

2022年北美微生物鑑定方法市值為211183萬美元，預計2030年將達到331978萬美元；預計2022年至2030年複合年成長率為5.8%。

日益成長的食品安全問題對微生物鑑定程序的需求推動了北美微生物鑑定方法市場的發展

食源性疾病 (FBD) 是一個普遍存在且不斷擴大的公共衛生和經濟問題。食源性感染的流行受到近期食品生產和加工方法的變化以及消費者不斷變化的飲食模式的影響。感染過程中已知病原體之間的相互作用是人們關注的問題之一，近年來又出現了新的困難。儘管擴大採用化學防腐劑、冷鏈以及對微生物的更多了解，但食源性疾病對於工業化國家和發展中國家來說都是一個重大的公共衛生問題。糧食安全集群估計，每年約有 42 萬人死亡，超過 6 億人（全球近十分之一的人）在食用受污染的食品後生病，導致 2022 年 6 月損失 3,300 萬傷殘調整生命年。

根據美國疾病管制與預防中心 (CDC) 2019 年的數據，每年，美國約有六分之一的人患有食源性疾病。沙門氏菌、大腸桿菌、彎曲桿菌和李斯特菌等細菌是許多食源性感染的原因。該國每年因食源性感染導致約 10 萬人入院治療和 3,000 人死亡。此外，每年有 400 萬加拿大人（即八分之一的加拿大人）因受污染的食物而生病。據估計，每年有 11,500 人因食源性疾病入院，240 人死亡。數字中包含了 30 種食源性病原體和不明原因的急性胃腸道疾病的估計。傳統方法是使用各種非選擇性和選擇性富集技術培養細菌，然後進行生化確認等。檢測時間是檢測食品時的重大限制，特別是那些保存期限較短的食品，如新鮮肉類、魚類、乳製品和蔬菜。幾種較新的檢測方法使用光譜方法，例如基質輔助雷射解吸電離飛行時間和高光譜成像協議。因此，食源性疾病病例的增加正在推動微生物鑑定方法市場。

北美微生物鑑定方法市場概況

由於醫療保健、製藥、食品和飲料以及環境監測等各個行業對準確、快速微生物鑑定的需求激增，北美微生物鑑定方法市場在過去幾年中經歷了大幅成長。這一成長歸因於多種因素，包括傳染病發病率的上升、食品和藥品生產中嚴格品質控制措施的需要，以及人們日益認知到微生物監測在維護公眾健康方面的重要性。根據 CDC 2022 年 11 月的最新情況，與冷凍沙拉三明治有關的大腸桿菌爆發導致 20 起病例和 5 起住院病例。

此外，技術的進步、創新微生物鑑定方法的引入以及重要參與者的存在預計將支持未來幾年的市場擴張。例如，BD Kiestra IdentifA系統旨在自動化準備微生物學細菌鑑定測試，於2022年1月獲得FDA 510(k)許可。系統從陽性血液培養物中快速辨識超過425 種細菌。此外，自動化和人工智慧 (AI) 對於簡化識別流程、減少人為錯誤和提高整體效率至關重要。製藥和生物技術領域是北美微生物鑑定市場成長的主要貢獻者。藥物開發、品質控制和法規遵循對微生物的精確鑑定的需要導致了對先進鑑定方法的高需求。因此，各種最終用戶對準確、快速微生物鑑定的需求不斷增加，傳染病發病率不斷上升，食品和藥品生產中嚴格品質控制措施的需要，以及對微生物監測在維護公眾健康方面的重要性的日益認知，這些都是迫切需要解決的問題。

北美微生物鑑定方法市場收入及 2030 年預測（百萬美元）

北美微生物鑑定方法市場細分

北美微生物鑑定方法市場根據方法、類型和國家進行細分。

根據方法，北美微生物鑑定方法市場分為基因型、表現型和蛋白質型。 2022 年，表現型細分市場佔最大佔有率。表現型部分再細分為儀器、試劑盒、試劑。蛋白型部分再細分為儀器、試劑盒、試劑。

依類型分類，北美微生物鑑定方法市場分為細菌鑑定系統、微生物計數系統、細菌抗藥性鑑定系統、微生物分析儀等。 2022 年，細菌辨識系統領域佔最大佔有率。

根據國家/地區，北美微生物鑑定方法市場分為美國和加拿大。 2022 年，美國將主導北美微生物鑑定方法市場。

Accelerate Diagnostics Inc、Avantor Inc、Becton Dickinson and Co、bioMerieux SA、Bruker Corp、Danaher Corp、Merck KGaA、Molzym GmbH & Co KG、Shimadzu Corp、Thermo Fisher Scientific Inc 是北美微生物鑑定領域的一些領先公司方法市場。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 重要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：北美微生物鑑定方法市場模式

  • 概述
  • 北美 PEST 分析

第 5 章：北美微生物鑑定方法市場 - 主要產業動態

  • 市場促進因素
    • 日益關注的食品安全問題要求微生物鑑定程序
    • 不同最終用戶對微生物鑑定方法的需求不斷成長
  • 市場限制
    • 自動化微生物辨識系統成本高昂
    • 由於複雜的規範架構，新微生物診斷測試的批准程序被推遲
  • 市場機會
    • 政府促進微生物鑑定的措施和資金
  • 未來的趨勢
    • 微生物鑑定技術的進步
  • 影響分析：

第 6 章：微生物鑑定方法市場 - 北美市場分析

  • 北美微生物鑑定方法市場收入，2020 - 2030

第 7 章：北美微生物鑑定方法市場 - 收入和 2030 年預測 - 按方法

  • 概述
  • 北美微生物鑑定方法市場收入佔有率，依方法 2022 年和 2030 年 (%)
  • 基因型
  • 表現型
  • 蛋白質型

第 8 章：北美微生物鑑定方法市場 - 收入和 2030 年預測 - 按類型

  • 概述
  • 北美微生物鑑定方法市場收入佔有率，按類型 2022 年和 2030 年 (%)
  • 細菌辨識系統
  • 微生物計數系統
  • 細菌抗藥性辨識系統
  • 微生物分析儀
  • 其他

第 9 章：北美微生物鑑定方法市場 - 國家分析

  • 北美洲
    • 美國
    • 加拿大

第 10 章：北美微生物鑑定方法市場產業格局

  • 概述
  • 北美微生物鑑定方法市場的成長策略
  • 無機成長策略
    • 概述
  • 有機成長策略
    • 概述

第 11 章：公司簡介

  • Avantor Inc
  • Becton Dickinson and Co
  • Danaher Corp
  • bioMerieux SA
  • Merck KGaA
  • Thermo Fisher Scientific Inc
  • Bruker Corp
  • Shimadzu Corp
  • Accelerate Diagnostics Inc
  • Molzym GmbH & Co KG
  • Biolog Inc

第 12 章：附錄

Product Code: BMIRE00029664

The North America microbial identification methods market was valued at US$ 2,111.83 million in 2022 and is expected to reach US$ 3,319.78 million by 2030; it is estimated to grow at a CAGR of 5.8% from 2022 to 2030.

Increasing Food Safety Concerns Demanding for Microbial Identification Procedure Fuel the North America Microbial Identification Methods Market

Foodborne diseases (FBD) are a prevalent and expanding public health and economic problem. The prevalence of foodborne infections is influenced by recent changes in food production and processing methods and consumers' ever-evolving eating patterns. The interaction between known pathogens during infection is one of the concerns, and new difficulties have emerged in recent years. Despite the rising adoption of chemical preservatives, cold chains, and a greater understanding of microbes, foodborne illnesses are a significant public health issue for both industrialized and developing nations. The Food Security Cluster estimates that each year, ~420,000 people die, and over 600 million people-nearly one in ten people worldwide-get sick after consuming contaminated food, resulting in a loss of 33 million DALYs in June 2022.

As per the Centers for Disease Control and Prevention (CDC) 2019, every year, about 1 in 6 people in the US have a foodborne disease. Bacteria, such as Salmonella, E. Coli, Campylobacter, and Listeria, are the cause of many foodborne infections. Foodborne infections cause about 100,000 hospital admissions and 3,000 fatalities annually in the country. Additionally, every year, 4 million Canadians, or 1 in 8 of the population, become ill from contaminated food. An estimated 11,500 hospital admissions and 240 fatalities are attributed to foodborne diseases annually. Both estimates for 30 foodborne pathogens and unidentified causes of acute gastrointestinal sickness are included in the numbers. The conventional approach is cultivating bacteria using a variety of nonselective and selective enrichment techniques, followed, among other things, by biochemical confirmation. The time-to-detection is a significant limitation when testing foods, especially those with short shelf lives like fresh meat, fish, dairy products, and vegetables. Several newer detection methods use spectroscopic approaches, such as matrix-assisted laser desorption ionization-time of flight and hyperspectral imaging protocols. Thus, the increase in cases of foodborne diseases is driving the microbial identification methods market.

North America Microbial Identification Methods Market Overview

The North America microbial identification method market has experienced substantial growth in the past few years due to an upsurge in demand for accurate and rapid microbial identification across various industries such as healthcare, pharmaceuticals, food & beverages, and environmental monitoring. The growth is attributed to several factors, including the rising incidence of infectious diseases, the need for stringent quality control measures in food and pharmaceutical production, and the growing awareness of the importance of microbial monitoring in maintaining public health. The E. coli outbreak connected to frozen falafel resulted in 20 instances of sickness and five hospitalizations, according to a November 2022 update from the CDC.

Furthermore, advancements in technology, the introduction of innovative microbial identification methods, and the existence of significant players are anticipated to support the market expansion in the coming years. For instance, the BD Kiestra IdentifA system, intended to automate the preparation of microbiology bacterial identification testing, received 510(k) clearance by the FDA in January 2022. In addition, Bruker Corporation, a US-based organization, introduced the MBT Sepsityper Kit IVD in January 2021 to quickly identify more than 425 bacteria from positive blood cultures using the MALDI Biotyper CA System. Additionally, automation and artificial intelligence (AI) are pivotal in streamlining the identification process, reducing human error, and improving overall efficiency. The pharmaceutical and biotechnology sectors are major contributors to the growth of the microbial identification market in North America. The need for precise identification of microorganisms for drug development, quality control, and regulatory compliance has led to a high demand for advanced identification methods. Thus, increasing demand for accurate and rapid microbial identification across various end users, rising incidence of infectious diseases, the need for stringent quality control measures in food and pharmaceutical production, and the growing awareness of the importance of microbial monitoring in maintaining public health are a few other factors driving the market in North America.

North America Microbial Identification Methods Market Revenue and Forecast to 2030 (US$ Million)

North America Microbial Identification Methods Market Segmentation

The North America microbial identification methods market is segmented based on method, type, and country.

Based on method, the North America microbial identification methods market is segmented into genotypic, phenotypic, and proteotypic. The phenotypic segment held the largest share in 2022. The genotypic segment is further subsegmented into instruments, kits, reagents. The phenotypic segment is further subsegmented into instruments, kits, reagents. The proteotypic segment is further subsegmented into instruments, kits, reagents.

By type, the North America microbial identification methods market is segmented into bacterial identification system, microbial enumeration system, bacterial resistance identification systems, microbiology analyzer, and others. The bacterial identification system segment held the largest share in 2022.

Based on country, the North America microbial identification methods market is bifurcated into the US and Canada. The US dominated the North America microbial identification methods market in 2022.

Accelerate Diagnostics Inc, Avantor Inc, Becton Dickinson and Co, bioMerieux SA, Bruker Corp, Danaher Corp, Merck KGaA, Molzym GmbH & Co KG, Shimadzu Corp, Thermo Fisher Scientific Inc are some of the leading companies operating in the North America microbial identification methods market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Microbial Identification Methods Market Landscape

  • 4.1 Overview
  • 4.2 North America PEST Analysis

5. North America Microbial Identification Methods Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Food Safety Concerns Demanding for Microbial Identification Procedure
    • 5.1.2 Rising Demand for Microbial Identification Methods Across Various End Users
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Automated Microbial Identification Systems
    • 5.2.2 Delay in Approval Process of New Microbial Diagnostic Test Due to Complex Regulatory Framework
  • 5.3 Market Opportunities
    • 5.3.1 Government Initiatives and Funding to Promote Microbial Identification
  • 5.4 Future Trends
    • 5.4.1 Advancements in Microbial Identification Techniques
  • 5.5 Impact Analysis:

6. Microbial Identification Methods Market - North America Market Analysis

  • 6.1 North America Microbial Identification Methods Market Revenue (US$ Mn), 2020 - 2030

7. North America Microbial Identification Methods Market - Revenue and Forecast to 2030 - by Method

  • 7.1 Overview
  • 7.2 North America Microbial Identification Methods Market Revenue Share, by Method 2022 & 2030 (%)
  • 7.3 Genotypic
    • 7.3.1 Overview
    • 7.3.2 Genotypic: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.1 North America Microbial Identification Methods Market, by Genotypic Product, 2020-2030 (US$ Million)
      • 7.3.2.2 North America Microbial Identification Methods Market, by Genotypic Microbe Type, 2020-2030 (US$ Million)
  • 7.4 Phenotypic
    • 7.4.1 Overview
    • 7.4.2 Phenotypic: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.4.2.1 North America Microbial Identification Methods Market, by Phenotypic Product, 2020-2030 (US$ Million)
      • 7.4.2.2 North America Microbial Identification Methods Market, by Phenotypic Microbe Type, 2020-2030 (US$ Million)
  • 7.5 Proteotypic
    • 7.5.1 Overview
    • 7.5.2 Proteotypic: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.5.2.1 North America Microbial Identification Methods Market, by Proteotypic Product, 2020-2030 (US$ Million)
      • 7.5.2.2 North America Microbial Identification Methods Market, by Proteotypic Microbe Type, 2020-2030 (US$ Million)

8. North America Microbial Identification Methods Market - Revenue and Forecast to 2030 - by Type

  • 8.1 Overview
  • 8.2 North America Microbial Identification Methods Market Revenue Share, by Type 2022 & 2030 (%)
  • 8.3 Bacterial Identification Systems
    • 8.3.1 Overview
    • 8.3.2 Bacterial Identification Systems: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Microbial Enumeration Systems
    • 8.4.1 Overview
    • 8.4.2 Microbial Enumeration System: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Bacterial Resistance Identification Systems
    • 8.5.1 Overview
    • 8.5.2 Bacterial Resistance Identification Systems: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Microbiology Analyzers
    • 8.6.1 Overview
    • 8.6.2 Microbiology Analyzer: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Microbial Identification Methods Market - Country Analysis

  • 9.1 North America
    • 9.1.1 North America Microbial Identification Methods Market, by Country
      • 9.1.1.1 US
        • 9.1.1.1.1 US: North America Microbial Identification Methods Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.1.2 US: North America Microbial Identification Methods Market, by Method
        • 9.1.1.1.2.1 US: North America Microbial Identification Methods Market, by Genotypic Product, 2020-2030 (US$ Million)
        • 9.1.1.1.2.2 US: North America Microbial Identification Methods Market, by Genotypic Microbe Type, 2020-2030 (US$ Million)
        • 9.1.1.1.2.3 US: North America Microbial Identification Methods Market, by Phenotypic Product, 2020-2030 (US$ Million)
        • 9.1.1.1.2.4 US: North America Microbial Identification Methods Market, by Phenotypic Microbe Type, 2020-2030 (US$ Million)
        • 9.1.1.1.2.5 US: North America Microbial Identification Methods Market, by Proteotypic Product, 2020-2030 (US$ Million)
        • 9.1.1.1.2.6 US: North America Microbial Identification Methods Market, by Proteotypic Microbe Type, 2020-2030 (US$ Million)
        • 9.1.1.1.3 US: North America Microbial Identification Methods Market, by Type
      • 9.1.1.2 Canada
        • 9.1.1.2.1 Canada: North America Microbial Identification Methods Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.2.2 Canada: North America Microbial Identification Methods Market, by Method
        • 9.1.1.2.2.1 Canada: North America Microbial Identification Methods Market, by Genotypic Product, 2020-2030 (US$ Million)
        • 9.1.1.2.2.2 Canada: North America Microbial Identification Methods Market, by Genotypic Microbe Type, 2020-2030 (US$ Million)
        • 9.1.1.2.2.3 Canada: North America Microbial Identification Methods Market, by Phenotypic Product, 2020-2030 (US$ Million)
        • 9.1.1.2.2.4 Canada: North America Microbial Identification Methods Market, by Phenotypic Microbe Type, 2020-2030 (US$ Million)
        • 9.1.1.2.2.5 Canada: North America Microbial Identification Methods Market, by Proteotypic Product, 2020-2030 (US$ Million)
        • 9.1.1.2.2.6 Canada: North America Microbial Identification Methods Market, by Proteotypic Microbe Type, 2020-2030 (US$ Million)
        • 9.1.1.2.3 Canada: North America Microbial Identification Methods Market, by Type

10. North America Microbial Identification Methods Market Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in the North America Microbial Identification Methods Market
  • 10.3 Inorganic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Organic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Avantor Inc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Becton Dickinson and Co
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Danaher Corp
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 bioMerieux SA
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Merck KGaA
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Thermo Fisher Scientific Inc
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Bruker Corp
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Shimadzu Corp
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 Accelerate Diagnostics Inc
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 Molzym GmbH & Co KG
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments
  • 11.11 Biolog Inc
    • 11.11.1 Key Facts
    • 11.11.2 Business Description
    • 11.11.3 Products and Services
    • 11.11.4 Financial Overview
    • 11.11.5 SWOT Analysis
    • 11.11.6 Key Developments

12. Appendix

  • 12.1 About Us
  • 12.2 Glossary of Terms

List Of Tables

  • Table 1. North America Microbial Identification Methods Market Segmentation
  • Table 2. North America Microbial Identification Methods Market, by Genotypic Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. North America Microbial Identification Methods Market, by Genotypic Microbe Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. North America Microbial Identification Methods Market, by Phenotypic Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. North America Microbial Identification Methods Market, by Phenotypic Microbe Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. North America Microbial Identification Methods Market, by Proteotypic Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. North America Microbial Identification Methods Market, by Proteotypic Microbe Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. US: North America Microbial Identification Methods Market Revenue And Forecast to 2030 (US$ Mn) - Methods
  • Table 9. US: North America Microbial Identification Methods Market, by Genotypic Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. US: North America Microbial Identification Methods Market, by Genotypic Microbe Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. US: North America Microbial Identification Methods Market, by Phenotypic Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. US: North America Microbial Identification Methods Market, by Phenotypic Microbe Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. US: North America Microbial Identification Methods Market, by Proteotypic Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. US: North America Microbial Identification Methods Market, by Proteotypic Microbe Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. US: North America Microbial Identification Methods Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 16. Canada: North America Microbial Identification Methods Market Revenue And Forecast to 2030 (US$ Mn) - Method
  • Table 17. Canada: North America Microbial Identification Methods Market, by Genotypic Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Canada: North America Microbial Identification Methods Market, by Genotypic Microbe Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Canada: North America Microbial Identification Methods Market, by Phenotypic Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Canada: North America Microbial Identification Methods Market, by Phenotypic Microbe Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Canada North America Microbial Identification Methods Market, by Proteotypic Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Canada: North America Microbial Identification Methods Market, by Proteotypic Microbe Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Canada: North America Microbial Identification Methods Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 24. Recent Inorganic Growth Strategies in the North America Microbial Identification Methods Market
  • Table 25. Recent Organic Growth Strategies in the North America Microbial Identification Methods Market
  • Table 26. Glossary of Terms, North America Microbial Identification Methods Market

List Of Figures

  • Figure 1. North America Microbial Identification Methods Market Segmentation, By Country
  • Figure 2. North America - PEST Analysis
  • Figure 3. North America Microbial Identification Methods Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. North America Microbial Identification Methods Market Revenue (US$ Mn), 2020 - 2030
  • Figure 6. North America Microbial Identification Methods Market Revenue Share, by Method 2022 & 2030 (%)
  • Figure 7. Genotypic: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Phenotypic: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Proteotypic: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. North America Microbial Identification Methods Market Revenue Share, by Type 2022 & 2030 (%)
  • Figure 11. Bacterial Identification System: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Microbial Enumeration System: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Bacterial Resistance Identification Systems: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Microbiology Analyzer: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Others: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. North America Microbial Identification Methods Market, 2022 ($Mn)
  • Figure 17. North America Microbial Identification Methods Market, By Key Countries, 2022 And 2030 (%)
  • Figure 18. US: North America Microbial Identification Methods Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 19. Canada: North America Microbial Identification Methods Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 20. Growth Strategies in the North America Microbial Identification Methods Market